| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | frizzled binding | 3.11e-09 | 42 | 111 | 7 | GO:0005109 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.75e-08 | 188 | 111 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B HSPG2 FSTL5 LRP1B RPH3A SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 UNC13C LTBP3 AGRN NOTCH3 CDH16 MASP2 | 1.59e-07 | 749 | 111 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | integrin binding | 6.08e-06 | 175 | 111 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 3.06e-05 | 2 | 111 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 3.06e-05 | 2 | 111 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 8.88e-05 | 16 | 111 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 1.11e-04 | 337 | 111 | 9 | GO:0001664 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.07e-04 | 21 | 111 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | transition metal ion binding | EPRS1 FN1 KDM5A WRN BIRC2 ZFAND5 PPARD TF CXXC1 RPH3A SIRT4 IKZF4 PGR RNF14 ZFAND6 RNF216 PHF14 | 2.97e-04 | 1189 | 111 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 3.96e-04 | 26 | 111 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | zinc ion binding | EPRS1 KDM5A BIRC2 ZFAND5 PPARD CXXC1 RPH3A SIRT4 IKZF4 PGR RNF14 ZFAND6 RNF216 PHF14 | 4.21e-04 | 891 | 111 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | cytokine activity | 4.99e-04 | 250 | 111 | 7 | GO:0005125 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 9.51e-04 | 547 | 111 | 10 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.05e-03 | 554 | 111 | 10 | GO:0030546 | |
| GeneOntologyMolecularFunction | collagen binding | 1.08e-03 | 81 | 111 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | structural molecule activity | CLDN14 HSPG2 RAPSN VWF FN1 LAMA3 LAMB3 SSPOP THBS2 KRT76 FBN1 MUC5AC AGRN | 1.34e-03 | 891 | 111 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.87e-03 | 599 | 111 | 10 | GO:0050839 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 3.62e-06 | 44 | 110 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | WNT1 WNT2 WNT6 WNT7A WNT11 WNT5B RNF14 CCN4 CELSR1 DRAXIN BAMBI RECK RNF138 | 3.75e-06 | 516 | 110 | 13 | GO:0016055 |
| GeneOntologyBiologicalProcess | tube development | PCSK5 HSPG2 DEAF1 FN1 WNT1 WNT2 WNT6 WNT7A WNT11 PLXND1 ACVR1 TEK PGR STAB1 THBS2 CELSR1 FBN1 PHF14 LTBP3 C5 RECK NOTCH3 | 4.05e-06 | 1402 | 110 | 22 | GO:0035295 |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.11e-05 | 198 | 110 | 8 | GO:0048754 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 1.57e-05 | 344 | 110 | 10 | GO:0060070 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 1.68e-05 | 101 | 110 | 6 | GO:0002028 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.00e-05 | 62 | 110 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | DEAF1 WNT1 WNT2 WNT6 WNT7A WNT11 PLXND1 ACVR1 TEK PGR WNT5B CELSR1 SCNN1B | 2.60e-05 | 619 | 110 | 13 | GO:0002009 |
| GeneOntologyBiologicalProcess | tube morphogenesis | HSPG2 DEAF1 FN1 WNT1 WNT2 WNT6 WNT7A WNT11 PLXND1 ACVR1 TEK PGR STAB1 THBS2 CELSR1 C5 RECK NOTCH3 | 2.70e-05 | 1125 | 110 | 18 | GO:0035239 |
| GeneOntologyBiologicalProcess | complement activation | 3.62e-05 | 70 | 110 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.92e-05 | 236 | 110 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cell junction assembly | CLDN14 FN1 WNT7A UBE3B WNT11 CPEB3 LAMA3 LRRTM3 PLXND1 TEK THBS2 AGRN | 5.21e-05 | 569 | 110 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | vasculature development | PCSK5 HSPG2 FN1 WNT2 WNT7A WNT11 ZFAND5 PLXND1 ACVR1 TEK SVEP1 STAB1 THBS2 C5 RECK NOTCH3 | 5.48e-05 | 969 | 110 | 16 | GO:0001944 |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B CLDN14 RAPSN FN1 WNT7A UBE3B WNT11 CPEB3 LAMA3 LRRTM3 PLXND1 TEK RPH3A SVEP1 THBS2 AGRN | 5.82e-05 | 974 | 110 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 6.91e-05 | 410 | 110 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 7.34e-05 | 258 | 110 | 8 | GO:0001763 | |
| GeneOntologyBiologicalProcess | positive regulation of motor neuron apoptotic process | 1.68e-04 | 4 | 110 | 2 | GO:2000673 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.68e-04 | 4 | 110 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | kidney development | 1.72e-04 | 372 | 110 | 9 | GO:0001822 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DEAF1 WNT1 WNT2 WNT6 WNT7A WNT11 PLXND1 ACVR1 TEK PGR WNT5B CELSR1 SCNN1B | 1.81e-04 | 750 | 110 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of locomotion | PCSK5 FN1 ADAM9 CARMIL1 WNT7A WNT11 LAMA3 PLXND1 ACVR1 PPARD TEK TF PGR WNT5B CCN4 C5 AGRN RECK | 2.21e-04 | 1327 | 110 | 18 | GO:0040012 |
| GeneOntologyBiologicalProcess | renal system development | 2.26e-04 | 386 | 110 | 9 | GO:0072001 | |
| GeneOntologyBiologicalProcess | Tie signaling pathway | 2.79e-04 | 5 | 110 | 2 | GO:0048014 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | UNC13B PCSK5 WNT1 CARMIL1 WNT7A WNT11 LRRTM3 TEK THBS2 CLU AGRN | 2.81e-04 | 582 | 110 | 11 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of fat cell differentiation | 2.84e-04 | 168 | 110 | 6 | GO:0045598 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HSPG2 DEAF1 FN1 WNT1 WNT2 ADAM9 WNT6 WNT7A WNT11 PLXND1 ACVR1 TEK CRB1 STAB1 THBS2 CELSR1 C5 RECK NOTCH3 | 3.00e-04 | 1483 | 110 | 19 | GO:0048646 |
| GeneOntologyBiologicalProcess | wound healing | 3.08e-04 | 493 | 110 | 10 | GO:0042060 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 WNT1 WNT2 WNT6 WNT7A WNT11 LAMA3 LAMB3 ZFAND5 PLXND1 ACVR1 TEK PGR CRB1 WNT5B CELSR1 LTBP3 | 3.90e-04 | 1269 | 110 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | negative regulation of synaptic plasticity | 4.17e-04 | 6 | 110 | 2 | GO:0031914 | |
| GeneOntologyBiologicalProcess | blood vessel development | PCSK5 HSPG2 FN1 WNT2 WNT7A WNT11 PLXND1 ACVR1 TEK STAB1 THBS2 C5 RECK NOTCH3 | 4.22e-04 | 929 | 110 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | HSPG2 DEAF1 FN1 WNT1 WNT2 WNT6 WNT7A WNT11 ACVR1 WNT5B CELSR1 RECK | 4.22e-04 | 713 | 110 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 4.26e-04 | 421 | 110 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | PCSK5 FN1 ADAM9 CARMIL1 WNT7A WNT11 LAMA3 PLXND1 ACVR1 PPARD TEK TF PGR WNT5B CCN4 C5 RECK | 4.30e-04 | 1280 | 110 | 17 | GO:2000145 |
| GeneOntologyBiologicalProcess | skeletal system development | PCSK5 HSPG2 DEAF1 WNT1 WNT7A WNT11 ZFAND5 TEK CCN4 FBN1 LTBP3 | 4.47e-04 | 615 | 110 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | cell fate commitment | 4.60e-04 | 338 | 110 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | embryo development | PCSK5 HSPG2 DEAF1 FN1 WNT1 WNT2 WNT6 WNT7A WNT11 LAMA3 ZFAND5 ACVR1 LRP1B WNT5B CELSR1 CCDC62 C5 RECK | 5.76e-04 | 1437 | 110 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 5.95e-04 | 31 | 110 | 3 | GO:0016082 | |
| GeneOntologyBiologicalProcess | circulatory system development | PCSK5 HSPG2 FN1 WNT2 WNT7A WNT11 ZFAND5 PLXND1 ACVR1 TEK SVEP1 STAB1 CCN4 THBS2 FBN1 C5 RECK NOTCH3 | 6.00e-04 | 1442 | 110 | 18 | GO:0072359 |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 6.28e-04 | 73 | 110 | 4 | GO:0071300 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 6.57e-04 | 273 | 110 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | HSPG2 FN1 WNT2 WNT7A PLXND1 TEK CIT STAB1 WNT5B THBS2 CELSR1 DRAXIN BAMBI C5 RECK | 6.71e-04 | 1090 | 110 | 15 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of cell migration | PCSK5 FN1 ADAM9 CARMIL1 WNT7A WNT11 LAMA3 PLXND1 ACVR1 PPARD TEK PGR WNT5B CCN4 C5 RECK | 6.82e-04 | 1211 | 110 | 16 | GO:0030334 |
| GeneOntologyBiologicalProcess | sodium ion transport | 6.86e-04 | 275 | 110 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 6.87e-04 | 131 | 110 | 5 | GO:0032526 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 6.96e-04 | 75 | 110 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | HSPG2 WNT1 WNT7A WNT11 PPARD TEK CIT STAB1 CCN4 THBS2 FBN1 DRAXIN BAMBI PHF14 LTBP3 NOTCH3 | 7.38e-04 | 1220 | 110 | 16 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 7.54e-04 | 202 | 110 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 7.68e-04 | 77 | 110 | 4 | GO:0035567 | |
| GeneOntologyBiologicalProcess | cell proliferation in midbrain | 7.73e-04 | 8 | 110 | 2 | GO:0033278 | |
| GeneOntologyBiologicalProcess | response to wounding | VWF FN1 WNT7A PPARD SVEP1 CCN4 CELSR1 TSPAN8 SCNN1B PLAUR C5 | 7.92e-04 | 659 | 110 | 11 | GO:0009611 |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 8.14e-04 | 136 | 110 | 5 | GO:1901890 | |
| GeneOntologyBiologicalProcess | axon guidance | 8.46e-04 | 285 | 110 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.64e-04 | 286 | 110 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | HSPG2 FN1 WNT7A WNT11 TEK CIT SVEP1 STAB1 CCN4 THBS2 FBN1 DRAXIN TSPAN8 RNF216 PHF14 PLAUR LTBP3 WNK3 | 8.65e-04 | 1488 | 110 | 18 | GO:0051241 |
| GeneOntologyBiologicalProcess | axonogenesis | 8.99e-04 | 566 | 110 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 9.27e-04 | 36 | 110 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 9.55e-04 | 291 | 110 | 7 | GO:0045444 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 9.69e-04 | 212 | 110 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell proliferation | 9.90e-04 | 9 | 110 | 2 | GO:0072201 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | FN1 WNT1 WNT7A BIRC2 PLXND1 ACVR1 PPARD TEK SIRT4 PGR DRAXIN CLU ZFAND6 PLAUR WNK3 | 9.95e-04 | 1133 | 110 | 15 | GO:0043066 |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 VWF FN1 WNT2 WNT6 WNT7A WNT11 LAMA3 LAMB3 LRRTM3 ADAM11 ADAMTSL3 SSPOP TF SVEP1 WNT5B CCN4 THBS2 FBN1 CLU LTBP3 MUC5AC AGRN | 7.44e-13 | 656 | 113 | 23 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 VWF FN1 WNT2 WNT6 WNT7A WNT11 LAMA3 LAMB3 LRRTM3 ADAM11 ADAMTSL3 SSPOP TF SVEP1 WNT5B CCN4 THBS2 FBN1 CLU LTBP3 MUC5AC AGRN | 7.92e-13 | 658 | 113 | 23 | GO:0030312 |
| GeneOntologyCellularComponent | Golgi lumen | 1.37e-07 | 109 | 113 | 8 | GO:0005796 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 VWF FN1 WNT2 LAMA3 LAMB3 ADAM11 SSPOP TF WNT5B THBS2 FBN1 CLU LTBP3 AGRN | 1.74e-07 | 530 | 113 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 3.28e-07 | 122 | 113 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.30e-05 | 332 | 113 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | Wnt signalosome | 8.18e-05 | 16 | 113 | 3 | GO:1990909 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.73e-04 | 4 | 113 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | membrane attack complex | 5.98e-04 | 7 | 113 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | cell surface | VWF WNT1 ADAM9 WNT6 WNT7A TEK TF GFRA3 WNT5B CLU TSPAN8 SCNN1B PLAUR AGRN NOTCH3 | 9.45e-04 | 1111 | 113 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.04e-03 | 212 | 113 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | laminin complex | 1.27e-03 | 10 | 113 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.63e-03 | 93 | 113 | 4 | GO:0031091 | |
| MousePheno | neonatal lethality, complete penetrance | RAPSN KDM5A WNT1 WNT11 LAMB3 ZFAND5 PLXND1 ACVR1 PHF21A SLC5A3 WFDC2 SCNN1B PHF14 AGRN | 2.03e-05 | 534 | 98 | 14 | MP:0011087 |
| Domain | EGF_1 | HSPG2 FN1 ADAM9 LAMA3 LAMB3 ADAM11 TEK SSPOP LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 C9 AGRN NOTCH3 MASP2 | 2.35e-18 | 255 | 111 | 21 | PS00022 |
| Domain | EGF-like_CS | HSPG2 FN1 ADAM9 LAMA3 LAMB3 ADAM11 TEK LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 C9 AGRN NOTCH3 MASP2 | 6.70e-17 | 261 | 111 | 20 | IPR013032 |
| Domain | EGF_2 | HSPG2 ADAM9 LAMA3 LAMB3 ADAM11 TEK SSPOP LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 C9 AGRN NOTCH3 MASP2 | 9.02e-17 | 265 | 111 | 20 | PS01186 |
| Domain | EGF-like_dom | PCSK5 HSPG2 ADAM9 LAMA3 ADAM11 TEK LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 C9 AGRN NOTCH3 MASP2 | 4.64e-16 | 249 | 111 | 19 | IPR000742 |
| Domain | EGF | PCSK5 HSPG2 ADAM9 LAMA3 ADAM11 TEK LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 AGRN NOTCH3 MASP2 | 2.74e-15 | 235 | 111 | 18 | SM00181 |
| Domain | EGF_3 | HSPG2 ADAM9 ADAM11 TEK SSPOP LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 C9 AGRN NOTCH3 MASP2 | 2.74e-15 | 235 | 111 | 18 | PS50026 |
| Domain | EGF_CA | HSPG2 LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 AGRN NOTCH3 MASP2 | 3.60e-13 | 122 | 111 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 LRP1B SVEP1 CRB1 STAB1 THBS2 CELSR1 FBN1 DLK2 LTBP3 AGRN NOTCH3 MASP2 | 4.45e-13 | 124 | 111 | 13 | IPR001881 |
| Domain | Growth_fac_rcpt_ | PCSK5 HSPG2 LAMA3 TEK LRP1B SVEP1 CRB1 STAB1 CCN4 CELSR1 FBN1 LTBP3 C9 NOTCH3 | 4.66e-13 | 156 | 111 | 14 | IPR009030 |
| Domain | Wnt | 9.79e-10 | 19 | 111 | 6 | IPR005817 | |
| Domain | WNT1 | 9.79e-10 | 19 | 111 | 6 | PS00246 | |
| Domain | Wnt_CS | 9.79e-10 | 19 | 111 | 6 | IPR018161 | |
| Domain | wnt | 9.79e-10 | 19 | 111 | 6 | PF00110 | |
| Domain | WNT1 | 9.79e-10 | 19 | 111 | 6 | SM00097 | |
| Domain | EGF_extracell | 2.39e-09 | 60 | 111 | 8 | IPR013111 | |
| Domain | EGF_2 | 2.39e-09 | 60 | 111 | 8 | PF07974 | |
| Domain | PHD | 2.85e-09 | 89 | 111 | 9 | SM00249 | |
| Domain | Znf_PHD | 3.48e-09 | 91 | 111 | 9 | IPR001965 | |
| Domain | EGF | 3.95e-09 | 126 | 111 | 10 | PF00008 | |
| Domain | ZF_PHD_2 | 5.11e-09 | 95 | 111 | 9 | PS50016 | |
| Domain | ZF_PHD_1 | 5.61e-09 | 96 | 111 | 9 | PS01359 | |
| Domain | ASX_HYDROXYL | 8.07e-09 | 100 | 111 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.35e-08 | 106 | 111 | 9 | IPR000152 | |
| Domain | PHD | 1.46e-08 | 75 | 111 | 8 | PF00628 | |
| Domain | Znf_FYVE_PHD | 1.75e-08 | 147 | 111 | 10 | IPR011011 | |
| Domain | EGF_LAM_2 | 2.03e-08 | 30 | 111 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 2.03e-08 | 30 | 111 | 6 | PS01248 | |
| Domain | EGF_Lam | 5.42e-08 | 35 | 111 | 6 | SM00180 | |
| Domain | Laminin_EGF | 5.42e-08 | 35 | 111 | 6 | PF00053 | |
| Domain | Laminin_EGF | 9.09e-08 | 38 | 111 | 6 | IPR002049 | |
| Domain | EGF_Ca-bd_CS | 1.12e-07 | 97 | 111 | 8 | IPR018097 | |
| Domain | Zinc_finger_PHD-type_CS | 1.13e-07 | 65 | 111 | 7 | IPR019786 | |
| Domain | EGF_CA | 1.32e-07 | 99 | 111 | 8 | PS01187 | |
| Domain | Znf_PHD-finger | 4.41e-07 | 79 | 111 | 7 | IPR019787 | |
| Domain | hEGF | 5.97e-07 | 28 | 111 | 5 | PF12661 | |
| Domain | EGF_CA | 7.90e-07 | 86 | 111 | 7 | PF07645 | |
| Domain | Laminin_G | 1.21e-06 | 58 | 111 | 6 | IPR001791 | |
| Domain | - | 1.55e-06 | 95 | 111 | 7 | 2.60.120.200 | |
| Domain | VWFC_1 | 2.20e-06 | 36 | 111 | 5 | PS01208 | |
| Domain | VWFC_2 | 2.91e-06 | 38 | 111 | 5 | PS50184 | |
| Domain | VWC | 2.91e-06 | 38 | 111 | 5 | SM00214 | |
| Domain | LAM_G_DOMAIN | 2.91e-06 | 38 | 111 | 5 | PS50025 | |
| Domain | Znf_RING/FYVE/PHD | RAPSN KDM5A BIRC2 CXXC1 RPH3A PHF21A RNF14 CHD5 PHF14 MLLT6 RNF138 KDM4B SP140 | 3.39e-06 | 459 | 111 | 13 | IPR013083 |
| Domain | CTCK_1 | 3.39e-06 | 18 | 111 | 4 | PS01185 | |
| Domain | LDLR_class-A_CS | 3.77e-06 | 40 | 111 | 5 | IPR023415 | |
| Domain | VWF_dom | 4.83e-06 | 42 | 111 | 5 | IPR001007 | |
| Domain | LamG | 6.11e-06 | 44 | 111 | 5 | SM00282 | |
| Domain | Ldl_recept_a | 6.85e-06 | 45 | 111 | 5 | PF00057 | |
| Domain | - | 7.64e-06 | 46 | 111 | 5 | 4.10.400.10 | |
| Domain | EPHD | 7.96e-06 | 22 | 111 | 4 | PS51805 | |
| Domain | LDLRA_1 | 9.46e-06 | 48 | 111 | 5 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.05e-05 | 49 | 111 | 5 | IPR002172 | |
| Domain | LDLa | 1.05e-05 | 49 | 111 | 5 | SM00192 | |
| Domain | LDLRA_2 | 1.05e-05 | 49 | 111 | 5 | PS50068 | |
| Domain | Cys_knot_C | 1.36e-05 | 25 | 111 | 4 | IPR006207 | |
| Domain | CTCK_2 | 1.36e-05 | 25 | 111 | 4 | PS01225 | |
| Domain | - | RAPSN KDM5A CXXC1 RPH3A PHF21A RNF14 CHD5 PHF14 MLLT6 RNF138 KDM4B SP140 | 1.48e-05 | 449 | 111 | 12 | 3.30.40.10 |
| Domain | VWC | 2.17e-05 | 28 | 111 | 4 | PF00093 | |
| Domain | TSP_1 | 3.62e-05 | 63 | 111 | 5 | PF00090 | |
| Domain | TSP1 | 4.21e-05 | 65 | 111 | 5 | SM00209 | |
| Domain | TSP1_rpt | 4.21e-05 | 65 | 111 | 5 | IPR000884 | |
| Domain | TSP1 | 4.21e-05 | 65 | 111 | 5 | PS50092 | |
| Domain | C8 | 4.32e-05 | 12 | 111 | 3 | PF08742 | |
| Domain | TIL | 4.32e-05 | 12 | 111 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 5.59e-05 | 13 | 111 | 3 | IPR014853 | |
| Domain | C8 | 5.59e-05 | 13 | 111 | 3 | SM00832 | |
| Domain | TIL_dom | 7.09e-05 | 14 | 111 | 3 | IPR002919 | |
| Domain | Laminin_G_2 | 9.16e-05 | 40 | 111 | 4 | PF02210 | |
| Domain | Unc-13 | 1.05e-04 | 3 | 111 | 2 | IPR027080 | |
| Domain | VWF_type-D | 1.08e-04 | 16 | 111 | 3 | IPR001846 | |
| Domain | VWFD | 1.08e-04 | 16 | 111 | 3 | PS51233 | |
| Domain | VWD | 1.08e-04 | 16 | 111 | 3 | SM00216 | |
| Domain | VWD | 1.08e-04 | 16 | 111 | 3 | PF00094 | |
| Domain | VWC_out | 1.85e-04 | 19 | 111 | 3 | SM00215 | |
| Domain | NKAIN | 2.08e-04 | 4 | 111 | 2 | PF05640 | |
| Domain | Na/K-Atpase_Interacting | 2.08e-04 | 4 | 111 | 2 | IPR008516 | |
| Domain | SEA | 2.90e-04 | 22 | 111 | 3 | PF01390 | |
| Domain | CT | 2.90e-04 | 22 | 111 | 3 | SM00041 | |
| Domain | SEA | 3.32e-04 | 23 | 111 | 3 | PS50024 | |
| Domain | SEA_dom | 3.32e-04 | 23 | 111 | 3 | IPR000082 | |
| Domain | ConA-like_dom | 3.35e-04 | 219 | 111 | 7 | IPR013320 | |
| Domain | VWA | 3.42e-04 | 56 | 111 | 4 | PF00092 | |
| Domain | Munc13_dom-2 | 3.46e-04 | 5 | 111 | 2 | IPR014772 | |
| Domain | MHD2 | 3.46e-04 | 5 | 111 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.46e-04 | 5 | 111 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 3.46e-04 | 5 | 111 | 2 | PF10540 | |
| Domain | DUF1041 | 3.46e-04 | 5 | 111 | 2 | SM01145 | |
| Domain | cEGF | 4.81e-04 | 26 | 111 | 3 | PF12662 | |
| Domain | cEGF | 4.81e-04 | 26 | 111 | 3 | IPR026823 | |
| Domain | Munc13_1 | 7.21e-04 | 7 | 111 | 2 | IPR014770 | |
| Domain | MHD1 | 7.21e-04 | 7 | 111 | 2 | PS51258 | |
| Domain | TB | 7.21e-04 | 7 | 111 | 2 | PF00683 | |
| Domain | ZF_A20 | 7.21e-04 | 7 | 111 | 2 | PS51036 | |
| Domain | zf-A20 | 7.21e-04 | 7 | 111 | 2 | PF01754 | |
| Domain | DUF1041 | 7.21e-04 | 7 | 111 | 2 | PF06292 | |
| Domain | Znf_A20 | 7.21e-04 | 7 | 111 | 2 | IPR002653 | |
| Domain | CAPS_dom | 7.21e-04 | 7 | 111 | 2 | IPR010439 | |
| Domain | ZnF_A20 | 7.21e-04 | 7 | 111 | 2 | SM00259 | |
| Domain | SAND_dom | 9.57e-04 | 8 | 111 | 2 | IPR000770 | |
| Domain | ZF_AN1 | 9.57e-04 | 8 | 111 | 2 | PS51039 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.28e-08 | 25 | 95 | 6 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 1.65e-08 | 26 | 95 | 6 | M27239 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.32e-07 | 36 | 95 | 6 | M39699 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.35e-07 | 19 | 95 | 5 | M47836 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.59e-07 | 44 | 95 | 6 | MM15878 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.09e-06 | 28 | 95 | 5 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.31e-06 | 29 | 95 | 5 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.31e-06 | 29 | 95 | 5 | M47377 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.34e-06 | 161 | 95 | 9 | M39770 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.50e-06 | 84 | 95 | 7 | M7098 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 1.77e-06 | 55 | 95 | 6 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.98e-06 | 56 | 95 | 6 | M1053 | |
| Pathway | WNT_SIGNALING | 2.22e-06 | 89 | 95 | 7 | M5493 | |
| Pathway | WP_WNT_SIGNALING | 3.29e-06 | 61 | 95 | 6 | MM15893 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 4.59e-06 | 37 | 95 | 5 | M47411 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 5.18e-06 | 101 | 95 | 7 | M39387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 5.18e-06 | 101 | 95 | 7 | MM15829 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.24e-06 | 66 | 95 | 6 | M18 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 9.20e-06 | 154 | 95 | 8 | M39739 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | FN1 WNT1 WNT2 WNT6 WNT7A WNT11 LAMA3 BIRC2 LAMB3 PPARD WNT5B | 1.15e-05 | 325 | 95 | 11 | M12868 |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.23e-05 | 45 | 95 | 5 | M47412 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 1.29e-05 | 116 | 95 | 7 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 1.37e-05 | 117 | 95 | 7 | M39530 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.38e-05 | 46 | 95 | 5 | M47409 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.45e-05 | 118 | 95 | 7 | M39852 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.62e-05 | 8 | 95 | 3 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 1.62e-05 | 8 | 95 | 3 | M27006 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 2.28e-05 | 85 | 95 | 6 | M48315 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 2.96e-05 | 89 | 95 | 6 | M39563 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | FN1 WNT1 WNT2 WNT6 WNT7A WNT11 LAMA3 LAMB3 TEK CIT WNT5B CDH16 | 3.77e-05 | 439 | 95 | 12 | M42563 |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 4.32e-05 | 58 | 95 | 5 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 4.69e-05 | 59 | 95 | 5 | M48343 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.69e-05 | 59 | 95 | 5 | M27218 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 4.70e-05 | 11 | 95 | 3 | MM1430 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.01e-05 | 143 | 95 | 7 | M27275 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 5.11e-05 | 98 | 95 | 6 | M39731 | |
| Pathway | KEGG_MELANOGENESIS | 6.05e-05 | 101 | 95 | 6 | M7761 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 6.24e-05 | 12 | 95 | 3 | M48316 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 7.07e-05 | 151 | 95 | 7 | M19428 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 8.07e-05 | 13 | 95 | 3 | M4732 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.32e-05 | 68 | 95 | 5 | M27303 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 9.74e-05 | 110 | 95 | 6 | M39492 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 9.99e-05 | 69 | 95 | 5 | M16894 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.13e-04 | 113 | 95 | 6 | M39669 | |
| Pathway | WP_CANCER_PATHWAYS | FN1 WNT1 WNT2 WNT6 WNT7A WNT11 LAMA3 BIRC2 LAMB3 PPARD WNT5B NOTCH3 | 1.49e-04 | 507 | 95 | 12 | M48302 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.88e-04 | 300 | 95 | 9 | M610 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.88e-04 | 17 | 95 | 3 | M212 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.88e-04 | 17 | 95 | 3 | MM1369 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.68e-04 | 85 | 95 | 5 | M16441 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.11e-04 | 20 | 95 | 3 | M917 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.63e-04 | 140 | 95 | 6 | M587 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 4.16e-04 | 22 | 95 | 3 | M39502 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.28e-04 | 94 | 95 | 5 | M797 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 6.63e-04 | 59 | 95 | 4 | M39886 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 7.41e-04 | 106 | 95 | 5 | M42535 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 8.60e-04 | 28 | 95 | 3 | M77 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 9.23e-04 | 7 | 95 | 2 | M47873 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.05e-03 | 30 | 95 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.05e-03 | 30 | 95 | 3 | M27216 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.16e-03 | 31 | 95 | 3 | MM1343 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.23e-03 | 8 | 95 | 2 | MM1582 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.23e-03 | 8 | 95 | 2 | M47850 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.28e-03 | 32 | 95 | 3 | MM14854 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.40e-03 | 33 | 95 | 3 | M6220 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.49e-03 | 250 | 95 | 7 | M27554 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 1.57e-03 | 9 | 95 | 2 | M47881 | |
| Pathway | WP_FOCAL_ADHESION | 1.65e-03 | 187 | 95 | 6 | MM15913 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.71e-03 | 76 | 95 | 4 | M27219 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.95e-03 | 37 | 95 | 3 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.11e-03 | 38 | 95 | 3 | MM14874 | |
| Pathway | WP_FOCAL_ADHESION | 2.25e-03 | 199 | 95 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.25e-03 | 199 | 95 | 6 | M7253 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.27e-03 | 39 | 95 | 3 | MM14601 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.27e-03 | 39 | 95 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.27e-03 | 39 | 95 | 3 | MM15165 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 2.38e-03 | 11 | 95 | 2 | M27372 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.38e-03 | 11 | 95 | 2 | M158 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.47e-03 | 84 | 95 | 4 | M3228 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.47e-03 | 84 | 95 | 4 | MM14653 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.63e-03 | 41 | 95 | 3 | M27778 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.84e-03 | 12 | 95 | 2 | MM1368 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.01e-03 | 43 | 95 | 3 | M53 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.21e-03 | 44 | 95 | 3 | M26969 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 3.34e-03 | 13 | 95 | 2 | M39582 | |
| Pathway | PID_PS1_PATHWAY | 3.65e-03 | 46 | 95 | 3 | M70 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.88e-03 | 47 | 95 | 3 | M646 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 3.88e-03 | 14 | 95 | 2 | M27263 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 4.01e-03 | 96 | 95 | 4 | M39581 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.01e-03 | 96 | 95 | 4 | M39834 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.12e-03 | 48 | 95 | 3 | M27642 | |
| Pathway | WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY | 4.12e-03 | 48 | 95 | 3 | M39427 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 4.28e-03 | 302 | 95 | 7 | M39719 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.46e-03 | 15 | 95 | 2 | M27161 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 4.46e-03 | 15 | 95 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 4.46e-03 | 15 | 95 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 4.46e-03 | 15 | 95 | 2 | MM14959 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.46e-03 | 15 | 95 | 2 | M7146 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 4.46e-03 | 15 | 95 | 2 | MM14961 | |
| Pubmed | 3.78e-13 | 21 | 114 | 7 | 17943183 | ||
| Pubmed | 5.30e-12 | 15 | 114 | 6 | 15044261 | ||
| Pubmed | 5.30e-12 | 15 | 114 | 6 | 11429295 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 6.45e-12 | 30 | 114 | 7 | 36305473 | |
| Pubmed | 8.46e-12 | 16 | 114 | 6 | 10585256 | ||
| Pubmed | 8.46e-12 | 16 | 114 | 6 | 9889131 | ||
| Pubmed | Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. | 1.92e-11 | 8 | 114 | 5 | 2279700 | |
| Pubmed | 2.10e-11 | 35 | 114 | 7 | 30940800 | ||
| Pubmed | 2.10e-11 | 35 | 114 | 7 | 23376422 | ||
| Pubmed | 2.10e-11 | 35 | 114 | 7 | 19185060 | ||
| Pubmed | 2.84e-11 | 19 | 114 | 6 | 11520664 | ||
| Pubmed | A new nomenclature for int-1 and related genes: the Wnt gene family. | 4.32e-11 | 9 | 114 | 5 | 1846319 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 5.66e-11 | 21 | 114 | 6 | 31914354 | |
| Pubmed | 7.76e-11 | 22 | 114 | 6 | 12815618 | ||
| Pubmed | Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. | 8.61e-11 | 10 | 114 | 5 | 8275860 | |
| Pubmed | 1.05e-10 | 23 | 114 | 6 | 27362799 | ||
| Pubmed | 1.90e-10 | 47 | 114 | 7 | 33141892 | ||
| Pubmed | 3.86e-10 | 28 | 114 | 6 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 3.86e-10 | 28 | 114 | 6 | 24394376 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 4.85e-10 | 29 | 114 | 6 | 22956684 | |
| Pubmed | 4.85e-10 | 29 | 114 | 6 | 18364260 | ||
| Pubmed | 6.05e-10 | 30 | 114 | 6 | 19282366 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 6.05e-10 | 30 | 114 | 6 | 21936019 | |
| Pubmed | 6.05e-10 | 30 | 114 | 6 | 15880404 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.54e-10 | 248 | 114 | 11 | 24006456 | |
| Pubmed | 1.41e-09 | 146 | 114 | 9 | 27068509 | ||
| Pubmed | Dual regulation of planar polarization by secreted Wnts and Vangl2 in the developing mouse cochlea. | 1.63e-09 | 35 | 114 | 6 | 32907846 | |
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 2.08e-09 | 17 | 114 | 5 | 8167409 | |
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 2.32e-09 | 37 | 114 | 6 | 35831952 | |
| Pubmed | 2.32e-09 | 37 | 114 | 6 | 15342465 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 2.75e-09 | 38 | 114 | 6 | 21041481 | |
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 2.75e-09 | 38 | 114 | 6 | 18635608 | |
| Pubmed | 2.75e-09 | 38 | 114 | 6 | 23190887 | ||
| Pubmed | 3.24e-09 | 39 | 114 | 6 | 24586192 | ||
| Pubmed | 3.80e-09 | 7 | 114 | 4 | 8058323 | ||
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 3.88e-09 | 19 | 114 | 5 | 28834739 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 6.76e-09 | 21 | 114 | 5 | 11914369 | |
| Pubmed | 6.92e-09 | 44 | 114 | 6 | 23884445 | ||
| Pubmed | 8.72e-09 | 22 | 114 | 5 | 18991257 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 1.04e-08 | 47 | 114 | 6 | 28813421 | |
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 1.04e-08 | 47 | 114 | 6 | 16678101 | |
| Pubmed | 1.04e-08 | 47 | 114 | 6 | 18351675 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 1.35e-08 | 49 | 114 | 6 | 19562671 | |
| Pubmed | 2.01e-08 | 90 | 114 | 7 | 19515997 | ||
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 2.26e-08 | 10 | 114 | 4 | 16258938 | |
| Pubmed | The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. | 2.26e-08 | 10 | 114 | 4 | 10866835 | |
| Pubmed | 2.64e-08 | 27 | 114 | 5 | 17804636 | ||
| Pubmed | UNC13B EPRS1 VWF FN1 KDM5A ADAM9 BIRC2 CIT LRP1B TF RPH3A DCAF5 STAB1 FBN1 CLU RNF216 PLAUR LTBP3 RECK | 3.86e-08 | 1285 | 114 | 19 | 35914814 | |
| Pubmed | 3.86e-08 | 29 | 114 | 5 | 22613833 | ||
| Pubmed | Dysregulated cell signalling and reduced satellite cell potential in ageing muscle. | 5.31e-08 | 12 | 114 | 4 | 31647919 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 17055474 | ||
| Pubmed | 1.20e-07 | 36 | 114 | 5 | 24151333 | ||
| Pubmed | 1.31e-07 | 71 | 114 | 6 | 33541421 | ||
| Pubmed | 1.32e-07 | 118 | 114 | 7 | 21078624 | ||
| Pubmed | Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | 1.39e-07 | 37 | 114 | 5 | 18800919 | |
| Pubmed | 1.93e-07 | 16 | 114 | 4 | 22677559 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 CACNA2D1 FN1 ADAM9 LAMA3 TF KRT76 GNA14 WFDC2 CLU TSPAN8 C5 C9 AGRN CDH16 MASP2 | 4.42e-07 | 1070 | 114 | 16 | 23533145 |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 4.76e-07 | 47 | 114 | 5 | 14760718 | |
| Pubmed | 6.28e-07 | 21 | 114 | 4 | 19806668 | ||
| Pubmed | 6.52e-07 | 50 | 114 | 5 | 23658023 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 1373817 | ||
| Pubmed | Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties. | 6.81e-07 | 6 | 114 | 3 | 7556445 | |
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 17064353 | ||
| Pubmed | 9.24e-07 | 23 | 114 | 4 | 31226309 | ||
| Pubmed | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. | 1.19e-06 | 7 | 114 | 3 | 11802174 | |
| Pubmed | 1.39e-06 | 167 | 114 | 7 | 22159717 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.55e-06 | 26 | 114 | 4 | 34189436 | |
| Pubmed | 1.89e-06 | 175 | 114 | 7 | 28071719 | ||
| Pubmed | Wnt-3a regulates somite and tailbud formation in the mouse embryo. | 1.90e-06 | 8 | 114 | 3 | 8299937 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | UBE2J1 HSPG2 CACNA2D1 LRP12 ADAM9 LAMB3 PLXND1 LRP1B CELSR1 FBN1 CLU PLAUR LTBP3 AGRN NOTCH3 SDHB | 1.99e-06 | 1201 | 114 | 16 | 35696571 |
| Pubmed | 2.23e-06 | 257 | 114 | 8 | 16335952 | ||
| Pubmed | 2.26e-06 | 64 | 114 | 5 | 22261194 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 12702652 | ||
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 3.06e-06 | 68 | 114 | 5 | 31112136 | |
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 3.22e-06 | 31 | 114 | 4 | 19344414 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 3.22e-06 | 31 | 114 | 4 | 31550482 | |
| Pubmed | Nkx2-5 regulates cardiac growth through modulation of Wnt signaling by R-spondin3. | 3.22e-06 | 31 | 114 | 4 | 25053429 | |
| Pubmed | 3.67e-06 | 32 | 114 | 4 | 31338035 | ||
| Pubmed | NOTCH maintains developmental cardiac gene network through WNT5A. | 3.67e-06 | 32 | 114 | 4 | 30347193 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 18992737 | ||
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 9891778 | ||
| Pubmed | HSPG2 VWF FN1 BCAT1 PPARD SVEP1 RNF14 ZNHIT6 CSRNP2 RNF216 LTBP3 | 4.12e-06 | 591 | 114 | 11 | 15231748 | |
| Pubmed | 4.71e-06 | 34 | 114 | 4 | 28069946 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 5.55e-06 | 11 | 114 | 3 | 36792666 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 5.67e-06 | 77 | 114 | 5 | 16944957 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.79e-06 | 135 | 114 | 6 | 28675934 | |
| Pubmed | Cardiac progenitors instruct second heart field fate through Wnts. | 7.38e-06 | 12 | 114 | 3 | 36649430 | |
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 7896292 | ||
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 15778975 | ||
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 16750824 | ||
| Pubmed | Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. | 9.58e-06 | 13 | 114 | 3 | 9811581 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 9.76e-06 | 86 | 114 | 5 | 28327460 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19037100 | ||
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 1.07e-05 | 2 | 114 | 2 | 26494287 | |
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 1.07e-05 | 2 | 114 | 2 | 25506919 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31589839 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 28321712 | ||
| Pubmed | Activin-like kinase 2 functions in peri-implantation uterine signaling in mice and humans. | 1.07e-05 | 2 | 114 | 2 | 24244176 | |
| Pubmed | Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. | 1.07e-05 | 2 | 114 | 2 | 7988795 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34968453 | ||
| Interaction | IGFL3 interactions | 3.11e-10 | 75 | 111 | 9 | int:IGFL3 | |
| Interaction | FBXO2 interactions | PCSK5 HSPG2 CACNA2D1 FN1 ADAM9 WNT7A LAMA3 LAMB3 PLXND1 LRP1B FBN1 AGRN NOTCH3 | 4.30e-07 | 411 | 111 | 13 | int:FBXO2 |
| Interaction | PORCN interactions | 1.51e-06 | 16 | 111 | 4 | int:PORCN | |
| Interaction | C9 interactions | 1.96e-06 | 17 | 111 | 4 | int:C9 | |
| Interaction | FZD9 interactions | 8.93e-06 | 8 | 111 | 3 | int:FZD9 | |
| Interaction | DYRK1A interactions | FN1 ADAM9 CIT LRP1B DCAF5 PPM1G STAB1 FBN1 CLU RNF216 PLAUR LTBP3 RECK | 1.10e-05 | 552 | 111 | 13 | int:DYRK1A |
| Interaction | C8B interactions | 1.33e-05 | 9 | 111 | 3 | int:C8B | |
| Interaction | C1orf54 interactions | 3.90e-05 | 167 | 111 | 7 | int:C1orf54 | |
| Interaction | ZDHHC15 interactions | 6.72e-05 | 125 | 111 | 6 | int:ZDHHC15 | |
| Cytoband | 22q13.3 | 9.11e-05 | 6 | 114 | 2 | 22q13.3 | |
| Cytoband | 1p22.3 | 1.37e-03 | 22 | 114 | 2 | 1p22.3 | |
| Cytoband | 12p13.3 | 2.54e-03 | 30 | 114 | 2 | 12p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 3.87e-03 | 415 | 114 | 5 | chr12q24 | |
| Cytoband | 3q22.1 | 4.93e-03 | 42 | 114 | 2 | 3q22.1 | |
| GeneFamily | Wnt family|Endogenous ligands | 2.88e-10 | 19 | 88 | 6 | 360 | |
| GeneFamily | PHD finger proteins | 2.74e-07 | 90 | 88 | 7 | 88 | |
| GeneFamily | Na+/K+ transporting ATPase interacting | 1.40e-04 | 4 | 88 | 2 | 659 | |
| GeneFamily | UNC13 homologs | 1.40e-04 | 4 | 88 | 2 | 836 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 4.84e-04 | 7 | 88 | 2 | 570 | |
| GeneFamily | Zinc fingers AN1-type|UPF1 like RNA helicases | 6.43e-04 | 8 | 88 | 2 | 63 | |
| GeneFamily | Laminin subunits | 1.50e-03 | 12 | 88 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 1.76e-03 | 13 | 88 | 2 | 634 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 3.04e-03 | 17 | 88 | 2 | 701 | |
| GeneFamily | Endogenous ligands | 6.02e-03 | 237 | 88 | 5 | 542 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 6.03e-03 | 24 | 88 | 2 | 485 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.60e-03 | 27 | 88 | 2 | 47 | |
| Coexpression | NABA_MATRISOME | VWA3A PCSK5 HSPG2 VWF FN1 WNT1 WNT2 ADAM9 WNT6 WNT7A WNT11 LAMA3 LAMB3 ADAM11 PLXND1 ADAMTSL3 SSPOP SVEP1 WNT5B CCN4 THBS2 FBN1 LTBP3 MUC5AC AGRN MASP2 | 1.27e-13 | 1008 | 113 | 26 | MM17056 |
| Coexpression | NABA_MATRISOME | VWA3A PCSK5 HSPG2 VWF FN1 WNT1 WNT2 ADAM9 WNT6 WNT7A WNT11 LAMA3 LAMB3 ADAM11 PLXND1 ADAMTSL3 SSPOP SVEP1 WNT5B CCN4 THBS2 FBN1 LTBP3 MUC5AC AGRN MASP2 | 1.91e-13 | 1026 | 113 | 26 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | VWA3A VWF FN1 LAMA3 LAMB3 SSPOP SVEP1 CCN4 THBS2 FBN1 LTBP3 AGRN | 4.12e-11 | 191 | 113 | 12 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | VWA3A VWF FN1 LAMA3 LAMB3 SSPOP SVEP1 CCN4 THBS2 FBN1 LTBP3 AGRN | 5.57e-11 | 196 | 113 | 12 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | VWA3A HSPG2 VWF FN1 LAMA3 LAMB3 SSPOP SVEP1 CCN4 THBS2 FBN1 LTBP3 AGRN | 1.69e-10 | 270 | 113 | 13 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | VWA3A HSPG2 VWF FN1 LAMA3 LAMB3 SSPOP SVEP1 CCN4 THBS2 FBN1 LTBP3 AGRN | 2.12e-10 | 275 | 113 | 13 | M5884 |
| Coexpression | HALLMARK_COAGULATION | 1.55e-07 | 138 | 113 | 8 | M5946 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.29e-07 | 162 | 113 | 8 | M45037 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.50e-06 | 20 | 113 | 4 | MM17053 | |
| Coexpression | GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 2.30e-06 | 197 | 113 | 8 | M8165 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 5.66e-06 | 59 | 113 | 5 | M47989 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 7.02e-06 | 163 | 113 | 7 | M12112 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.25e-05 | 178 | 113 | 7 | M17079 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 WNT1 WNT2 ADAM9 WNT6 WNT7A WNT11 ADAM11 PLXND1 ADAMTSL3 WNT5B MUC5AC MASP2 | 1.82e-05 | 738 | 113 | 13 | MM17058 |
| Coexpression | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS | 1.94e-05 | 37 | 113 | 4 | M12802 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 WNT1 WNT2 ADAM9 WNT6 WNT7A WNT11 ADAM11 PLXND1 ADAMTSL3 WNT5B MUC5AC MASP2 | 2.18e-05 | 751 | 113 | 13 | M5885 |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_DN | 2.47e-05 | 133 | 113 | 6 | M6767 | |
| Coexpression | GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 2.64e-05 | 200 | 113 | 7 | M6990 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.66e-05 | 40 | 113 | 4 | M5887 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 2.93e-05 | 41 | 113 | 4 | M47988 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 3.23e-05 | 42 | 113 | 4 | M5895 | |
| Coexpression | MEL18_DN.V1_UP | 3.43e-05 | 141 | 113 | 6 | M2784 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 3.55e-05 | 43 | 113 | 4 | M1551 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 3.55e-05 | 43 | 113 | 4 | MM666 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | VWA3A ADAM9 WNT7A ACVR1 SSPOP LRP1B TF CRB1 CELSR1 NKAIN4 CLU | 3.91e-05 | 574 | 113 | 11 | M39056 |
| Coexpression | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN | 4.65e-05 | 46 | 113 | 4 | M14142 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 5.08e-05 | 17 | 113 | 3 | MM1225 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 5.08e-05 | 17 | 113 | 3 | M1767 | |
| Coexpression | AIZARANI_LIVER_C17_HEPATOCYTES_3 | 8.13e-05 | 102 | 113 | 5 | M39119 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.30e-04 | 23 | 113 | 3 | M48001 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.41e-04 | 261 | 113 | 7 | M1834 | |
| Coexpression | HOOI_ST7_TARGETS_DN | 1.43e-04 | 115 | 113 | 5 | M14801 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT | 1.48e-04 | 24 | 113 | 3 | M38986 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | 1.68e-04 | 359 | 113 | 8 | M15193 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 1.85e-04 | 364 | 113 | 8 | M39057 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP | 2.17e-04 | 197 | 113 | 6 | M4975 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP | 2.17e-04 | 197 | 113 | 6 | M4993 | |
| Coexpression | GSE27786_BCELL_VS_CD4_TCELL_DN | 2.23e-04 | 198 | 113 | 6 | M4800 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.28e-04 | 69 | 113 | 4 | M10165 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN | 2.29e-04 | 199 | 113 | 6 | M8542 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 2.29e-04 | 199 | 113 | 6 | M7190 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 2.35e-04 | 200 | 113 | 6 | M8030 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN | 2.35e-04 | 200 | 113 | 6 | M3264 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 2.35e-04 | 200 | 113 | 6 | M3413 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 2.35e-04 | 200 | 113 | 6 | M7431 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 2.35e-04 | 200 | 113 | 6 | M5915 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP | 2.35e-04 | 200 | 113 | 6 | M4297 | |
| Coexpression | PLASARI_NFIC_TARGETS_BASAL_UP | 2.63e-04 | 29 | 113 | 3 | MM944 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 2.63e-04 | 29 | 113 | 3 | M47987 | |
| Coexpression | PLASARI_NFIC_TARGETS_BASAL_UP | 2.91e-04 | 30 | 113 | 3 | M2447 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.99e-04 | 74 | 113 | 4 | M13547 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 3.13e-04 | 211 | 113 | 6 | M12225 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | IKZF3 WNT1 WNT2 WNT6 WNT7A WNT11 KCNK13 PGR WNT5B THBS2 FBN1 GNA14 CHD5 DLK2 | 3.18e-04 | 1115 | 113 | 14 | M10371 |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 3.21e-04 | 31 | 113 | 3 | M18395 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 3.53e-04 | 32 | 113 | 3 | M5903 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 4.20e-04 | 145 | 113 | 5 | M2779 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 4.24e-04 | 34 | 113 | 3 | M14043 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.62e-04 | 35 | 113 | 3 | MM17054 | |
| Coexpression | DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS | 4.62e-04 | 35 | 113 | 3 | M40083 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_500 | 1.98e-05 | 105 | 112 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k2 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.62e-05 | 466 | 112 | 11 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#1_top-relative-expression-ranked_200 | 5.23e-05 | 39 | 112 | 4 | gudmap_developingKidney_e15.5_S-shaped body_200_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | CACNA2D1 VWF FN1 WNT7A WNT11 PLXND1 ACVR1 CXXC1 SVEP1 PHF21A IKZF4 STAB1 THBS2 FBN1 NKAIN4 CCDC62 RECK KDM4B | 5.99e-05 | 1208 | 112 | 18 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_100 | 6.16e-05 | 79 | 112 | 5 | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_100 | 6.21e-05 | 15 | 112 | 3 | gudmap_developingKidney_e15.5_S-shaped body_100_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_100 | 7.61e-05 | 16 | 112 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_100_k5 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CACNA2D1 FN1 ADAM9 LRRTM3 PLXND1 TEK FBN1 WFDC2 TSPAN8 SCNN1B AGRN RECK NOTCH3 CDH16 SP140 | 8.19e-05 | 905 | 112 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 9.77e-05 | 87 | 112 | 5 | GSM777050_100 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.09e-04 | 89 | 112 | 5 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.09e-04 | 89 | 112 | 5 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.21e-04 | 91 | 112 | 5 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.27e-04 | 361 | 112 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | FN1 WNT1 WNT2 WNT6 TF SVEP1 CRB1 WNT5B CCN4 THBS2 FBN1 NKAIN4 WFDC2 BAMBI PLAUR | 1.42e-04 | 951 | 112 | 15 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.63e-04 | 219 | 112 | 7 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_100 | 1.89e-04 | 100 | 112 | 5 | PCBC_EB_100 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | LRP12 VWF FN1 TMPRSS11E WNT11 LAMB3 SSPOP SLC5A3 WFDC2 TSPAN8 BAMBI MLLT6 PLAUR LTBP3 C5 | 2.01e-04 | 982 | 112 | 15 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | VWA3A FN1 WNT1 WNT2 WNT6 WNT7A WNT11 LRP1B TF SVEP1 CRB1 CCN4 NKAIN4 BAMBI NKAIN1 | 2.29e-04 | 994 | 112 | 15 | PCBC_EB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PCSK5 CACNA2D1 FN1 LRRTM3 ACVR1 SVEP1 CCN4 FBN1 GNA14 CLU DEFB119 RECK WNK3 | 2.81e-04 | 793 | 112 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_500 | 3.23e-04 | 62 | 112 | 4 | gudmap_developingKidney_e15.5_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | PCSK5 CACNA2D1 LRP12 VWF FN1 WNT7A WNT11 LRRTM3 TF SVEP1 IKZF4 CCN4 THBS2 FBN1 LTBP3 UPP2 | 3.41e-04 | 1148 | 112 | 16 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | CARMIL1 LAMA3 LAMB3 BCAT1 CELSR1 WFDC2 CLU SCNN1B LTBP3 WNK3 | 9.92e-11 | 198 | 114 | 10 | 85f424cd9bb3117c9e322031024aabb87696ce47 |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.24e-09 | 198 | 114 | 9 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.16e-09 | 159 | 114 | 8 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-08 | 173 | 114 | 8 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-08 | 173 | 114 | 8 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-08 | 177 | 114 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-08 | 181 | 114 | 8 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-08 | 181 | 114 | 8 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-08 | 181 | 114 | 8 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-08 | 182 | 114 | 8 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-08 | 182 | 114 | 8 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.45e-08 | 183 | 114 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-08 | 187 | 114 | 8 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-08 | 187 | 114 | 8 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-08 | 189 | 114 | 8 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-08 | 189 | 114 | 8 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 192 | 114 | 8 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-08 | 192 | 114 | 8 | 25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-08 | 192 | 114 | 8 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-08 | 192 | 114 | 8 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 192 | 114 | 8 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.70e-08 | 193 | 114 | 8 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 3.70e-08 | 193 | 114 | 8 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-08 | 193 | 114 | 8 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-08 | 194 | 114 | 8 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-08 | 194 | 114 | 8 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.01e-08 | 195 | 114 | 8 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-08 | 195 | 114 | 8 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-08 | 196 | 114 | 8 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-08 | 196 | 114 | 8 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.34e-08 | 197 | 114 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.51e-08 | 198 | 114 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.51e-08 | 198 | 114 | 8 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 4.69e-08 | 199 | 114 | 8 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.69e-08 | 199 | 114 | 8 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.69e-08 | 199 | 114 | 8 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.69e-08 | 199 | 114 | 8 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 4.87e-08 | 200 | 114 | 8 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-07 | 152 | 114 | 7 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.85e-07 | 170 | 114 | 7 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.46e-07 | 175 | 114 | 7 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-07 | 176 | 114 | 7 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-07 | 176 | 114 | 7 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-07 | 178 | 114 | 7 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.35e-07 | 181 | 114 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.35e-07 | 181 | 114 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 182 | 114 | 7 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 182 | 114 | 7 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.51e-07 | 182 | 114 | 7 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.51e-07 | 182 | 114 | 7 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-07 | 182 | 114 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-07 | 183 | 114 | 7 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-07 | 183 | 114 | 7 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 4.68e-07 | 183 | 114 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-07 | 183 | 114 | 7 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-07 | 183 | 114 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.86e-07 | 184 | 114 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-07 | 184 | 114 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.86e-07 | 184 | 114 | 7 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.86e-07 | 184 | 114 | 7 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-07 | 185 | 114 | 7 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | 21-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 5.22e-07 | 186 | 114 | 7 | f8cddad28896f0edf10a8645fa49a011b22b120d | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-07 | 186 | 114 | 7 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-07 | 186 | 114 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-07 | 186 | 114 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-07 | 186 | 114 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.41e-07 | 187 | 114 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 5.41e-07 | 187 | 114 | 7 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-07 | 188 | 114 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-07 | 188 | 114 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-07 | 189 | 114 | 7 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.82e-07 | 189 | 114 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-07 | 189 | 114 | 7 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 189 | 114 | 7 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-07 | 190 | 114 | 7 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.03e-07 | 190 | 114 | 7 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.03e-07 | 190 | 114 | 7 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 191 | 114 | 7 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-07 | 191 | 114 | 7 | 116fba9badea093e11f370996247cca0e4c02e8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-07 | 191 | 114 | 7 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.24e-07 | 191 | 114 | 7 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.24e-07 | 191 | 114 | 7 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-07 | 192 | 114 | 7 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.46e-07 | 192 | 114 | 7 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-07 | 192 | 114 | 7 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.46e-07 | 192 | 114 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-07 | 192 | 114 | 7 | d5ec4cdb15620a5abfc83577353501186c2bc86a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-07 | 192 | 114 | 7 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-07 | 192 | 114 | 7 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-07 | 192 | 114 | 7 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-07 | 192 | 114 | 7 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-07 | 193 | 114 | 7 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-07 | 193 | 114 | 7 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.69e-07 | 193 | 114 | 7 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-07 | 193 | 114 | 7 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.69e-07 | 193 | 114 | 7 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| Computational | ECM and collagens. | 2.77e-05 | 225 | 76 | 9 | MODULE_47 | |
| Computational | Adhesion molecules. | 5.92e-05 | 141 | 76 | 7 | MODULE_122 | |
| Computational | Genes in the cancer module 58. | 4.12e-04 | 21 | 76 | 3 | MODULE_58 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.15e-04 | 50 | 76 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.15e-04 | 50 | 76 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.15e-04 | 50 | 76 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION | |
| Computational | Complement. | 5.43e-04 | 23 | 76 | 3 | MODULE_130 | |
| Computational | Neighborhood of CDH11 | 6.99e-04 | 25 | 76 | 3 | GNF2_CDH11 | |
| Computational | Lung genes. | 9.10e-04 | 434 | 76 | 10 | MODULE_5 | |
| Computational | Ovary genes. | 1.10e-03 | 368 | 76 | 9 | MODULE_1 | |
| Drug | 2,3-pentanedione | 1.65e-08 | 129 | 113 | 9 | ctd:C013186 | |
| Drug | pyrachlostrobin | HSPG2 DEAF1 FN1 ADAM9 ADAM11 ADAMTSL3 SVEP1 DENND4C STAB1 WNT5B CCN4 THBS2 CELSR1 FBN1 PLAUR LTBP3 NOTCH3 | 5.21e-07 | 811 | 113 | 17 | ctd:C513428 |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A | 6.77e-07 | 199 | 113 | 9 | 2341_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.08e-06 | 155 | 113 | 8 | 6817_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A | 7.17e-06 | 200 | 113 | 8 | 3_UP | |
| Disease | Colorectal Carcinoma | UNC13B FN1 FSTL5 WRN LAMB3 ADAMTSL3 ZNF442 NCDN ZNHIT6 CCDC62 CHD5 SCNN1B | 1.81e-05 | 702 | 114 | 12 | C0009402 |
| Disease | Junctional epidermolysis bullosa | 4.43e-05 | 3 | 114 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 4.43e-05 | 3 | 114 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 4.43e-05 | 3 | 114 | 2 | 226700 | |
| Disease | Herlitz Disease | 8.83e-05 | 4 | 114 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 8.83e-05 | 4 | 114 | 2 | C0079297 | |
| Disease | pulse pressure measurement | RAPSN FN1 KDM5A CARMIL1 WNT7A ADAMTSL3 SSPOP RPH3A SVEP1 DENND4C THBS2 ASAP2 FBN1 LTBP3 NOTCH3 KDM4B | 9.07e-05 | 1392 | 114 | 16 | EFO_0005763 |
| Disease | Geleophysic dysplasia | 1.47e-04 | 5 | 114 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.47e-04 | 5 | 114 | 2 | C0265287 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.47e-04 | 5 | 114 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.47e-04 | 5 | 114 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.47e-04 | 5 | 114 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Pathologic Neovascularization | 2.20e-04 | 6 | 114 | 2 | C0027686 | |
| Disease | Junctional Epidermolysis Bullosa | 2.20e-04 | 6 | 114 | 2 | C0079301 | |
| Disease | Complement deficiency disease | 2.82e-04 | 33 | 114 | 3 | C0272242 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.07e-04 | 7 | 114 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 3.07e-04 | 7 | 114 | 2 | C0399367 | |
| Disease | exfoliation syndrome (is_implicated_in) | 3.07e-04 | 7 | 114 | 2 | DOID:13641 (is_implicated_in) | |
| Disease | lysophosphatidylethanolamine 18:1 measurement | 3.08e-04 | 34 | 114 | 3 | EFO_0010368 | |
| Disease | liver fibrosis measurement | 3.52e-04 | 86 | 114 | 4 | EFO_0010576 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 4.08e-04 | 8 | 114 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 4.08e-04 | 8 | 114 | 2 | EFO_0800420 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.16e-04 | 169 | 114 | 5 | DOID:3908 (is_marker_for) | |
| Disease | uric acid measurement | 6.15e-04 | 610 | 114 | 9 | EFO_0004761 | |
| Disease | pancreatic cancer (is_marker_for) | 6.47e-04 | 101 | 114 | 4 | DOID:1793 (is_marker_for) | |
| Disease | alopecia areata (is_marker_for) | 6.52e-04 | 10 | 114 | 2 | DOID:986 (is_marker_for) | |
| Disease | Alcohol Use Disorder | 6.63e-04 | 44 | 114 | 3 | C0001956 | |
| Disease | urate measurement | CLDN14 RAPSN CARMIL1 CXXC1 RPH3A PHF21A STAB1 ASAP2 ZNHIT6 ZNF816 KDM4B | 7.08e-04 | 895 | 114 | 11 | EFO_0004531 |
| Disease | end stage renal disease (is_marker_for) | 7.55e-04 | 46 | 114 | 3 | DOID:783 (is_marker_for) | |
| Disease | interleukin-6 measurement, response to stimulus | 7.95e-04 | 11 | 114 | 2 | EFO_0004810, GO_0050896 | |
| Disease | retinal drusen | 1.02e-03 | 51 | 114 | 3 | EFO_1001155 | |
| Disease | adult onset asthma | 1.16e-03 | 118 | 114 | 4 | EFO_1002011 | |
| Disease | hepcidin:ferritin ratio | 1.27e-03 | 55 | 114 | 3 | EFO_0007901 | |
| Disease | amino acid measurement | 1.29e-03 | 678 | 114 | 9 | EFO_0005134 | |
| Disease | Impaired cognition | 1.31e-03 | 14 | 114 | 2 | C0338656 | |
| Disease | depressive symptom measurement | 1.36e-03 | 426 | 114 | 7 | EFO_0007006 | |
| Disease | delta-6 desaturase measurement | 1.50e-03 | 15 | 114 | 2 | EFO_0007765 | |
| Disease | gamma-glutamylphenylalanine measurement | 1.50e-03 | 15 | 114 | 2 | EFO_0021142 | |
| Disease | Proteinuria | 1.50e-03 | 15 | 114 | 2 | HP_0000093 | |
| Disease | esterified cholesterol measurement | 1.56e-03 | 128 | 114 | 4 | EFO_0008589 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.56e-03 | 128 | 114 | 4 | DOID:4450 (is_marker_for) | |
| Disease | inflammatory bowel disease | 1.84e-03 | 449 | 114 | 7 | EFO_0003767 | |
| Disease | Antibody Deficiency Syndrome | 1.94e-03 | 17 | 114 | 2 | C0003257 | |
| Disease | triacylglycerol 56:3 measurement | 2.17e-03 | 18 | 114 | 2 | EFO_0010430 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 2.17e-03 | 18 | 114 | 2 | EFO_0010365 | |
| Disease | spine bone size | 2.17e-03 | 18 | 114 | 2 | EFO_0004508 | |
| Disease | carotid artery disease (is_marker_for) | 2.42e-03 | 19 | 114 | 2 | DOID:3407 (is_marker_for) | |
| Disease | anorectal malformation | 2.42e-03 | 19 | 114 | 2 | MONDO_0019938 | |
| Disease | glomerulonephritis (is_marker_for) | 2.42e-03 | 19 | 114 | 2 | DOID:2921 (is_marker_for) | |
| Disease | Meningioma | 2.42e-03 | 19 | 114 | 2 | C0025286 | |
| Disease | respiratory system disease | 2.46e-03 | 145 | 114 | 4 | EFO_0000684 | |
| Disease | eosinophil percentage of leukocytes | 2.47e-03 | 746 | 114 | 9 | EFO_0007991 | |
| Disease | asthma | 2.58e-03 | 751 | 114 | 9 | MONDO_0004979 | |
| Disease | Takayasu arteritis | 2.65e-03 | 148 | 114 | 4 | EFO_1001857 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.65e-03 | 148 | 114 | 4 | C0279702 | |
| Disease | iron biomarker measurement, transferrin measurement | 2.69e-03 | 20 | 114 | 2 | EFO_0004461, EFO_0006341 | |
| Disease | breast cancer (is_implicated_in) | 2.78e-03 | 150 | 114 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | melanoma | 2.81e-03 | 248 | 114 | 5 | C0025202 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 2.96e-03 | 21 | 114 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | 2.99e-03 | 1074 | 114 | 11 | C0006142 | |
| Disease | peak expiratory flow | 3.27e-03 | 498 | 114 | 7 | EFO_0009718 | |
| Disease | Manic | 3.46e-03 | 78 | 114 | 3 | C0338831 | |
| Disease | total iron binding capacity | 3.46e-03 | 78 | 114 | 3 | EFO_0006334 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.50e-03 | 160 | 114 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 3.55e-03 | 23 | 114 | 2 | C0021051 | |
| Disease | Glioblastoma | 3.59e-03 | 79 | 114 | 3 | C0017636 | |
| Disease | Carcinomatosis | 3.74e-03 | 163 | 114 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 3.74e-03 | 163 | 114 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 3.74e-03 | 163 | 114 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 3.74e-03 | 163 | 114 | 4 | C0205696 | |
| Disease | epilepsy (implicated_via_orthology) | 3.74e-03 | 163 | 114 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Carcinoma | 3.82e-03 | 164 | 114 | 4 | C0007097 | |
| Disease | Myasthenic Syndromes, Congenital | 3.86e-03 | 24 | 114 | 2 | C0751882 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKEMVGGCCVCSDER | 1 | P55198 | |
| MKDCSNGCSAECTGE | 1 | P54687 | |
| SCCQKNEACLGESGM | 496 | Q6P9F0 | |
| NEACLGESGMCDSKC | 501 | Q6P9F0 | |
| MEFCRVCKDGGELLC | 416 | Q8TDI0 | |
| CACSQAGIKCQVDRM | 226 | Q9H175 | |
| RDDCEQMTGLCSCKP | 856 | O00468 | |
| KLYMCVCEGLSCGNE | 31 | Q04771 | |
| KCTLTHDAMCSDGLC | 476 | O75078 | |
| DGCECCKMCAQQLGD | 71 | O95388 | |
| CKMCAQQLGDNCTEA | 76 | O95388 | |
| HSRTCDMATGQCACK | 2011 | Q9NYQ6 | |
| GRQASKCLECQVMCH | 1386 | O14578 | |
| ERGSMGTSGEACRCK | 881 | P98160 | |
| NDDAMLECRVCCSLG | 156 | Q13702 | |
| KICSCGQSGLLENCM | 556 | O95980 | |
| GEECRMSGECQSAVC | 491 | Q01546 | |
| DAGMCGLCQKAQLER | 561 | Q96RG2 | |
| CPNGRDETNCTMCQK | 401 | Q9Y561 | |
| NMCRVNNGGCSTLCL | 796 | Q9NZR2 | |
| PCSCGRRLCEEMTGQ | 1311 | Q16787 | |
| AAMPECDRDSGQCRC | 1366 | Q16787 | |
| MSCCDLAAAGQLGKA | 1 | Q9UBB6 | |
| EVQRMTGNDVCCDCG | 426 | O43150 | |
| CSSCQEGLQLLRGMC | 1146 | Q92824 | |
| CSQCLGREDLGHLCM | 856 | Q9Y4D7 | |
| CLDRIGQFTCICMAG | 446 | Q9UM47 | |
| GTLLHKDCCGSEMAC | 876 | Q96JK2 | |
| CSVCRKSGQLLMCDT | 491 | Q96BD5 | |
| ECCLCNLRGGALQMT | 796 | O94953 | |
| LRKMDSGCCPQCQRG | 291 | Q9HB14 | |
| DEARMSKDGCCRFCP | 5506 | P98088 | |
| LRCMGNSGICRASCK | 26 | Q8N690 | |
| RTGVCISCDAGMCRA | 451 | O94880 | |
| CRKTASGFMLQCELC | 1166 | P29375 | |
| CVTSRETGQAECACM | 76 | Q8N475 | |
| ETGQAECACMDLCKR | 81 | Q8N475 | |
| ACRLRKCCQAGMVLG | 621 | P06401 | |
| QIKRSARMCGECEAC | 161 | Q9P0U4 | |
| NNKCFDDCMCVEGLR | 301 | Q8NBI3 | |
| GHENCCLTCDKMRQA | 221 | Q13145 | |
| GCLQNSVLCSCRMEG | 81 | Q8NAE3 | |
| SGIACACAVIGMKCT | 91 | O95500 | |
| ACAVIGMKCTRCAKG | 96 | O95500 | |
| LDDQMCDECQGTRCG | 631 | Q8NE35 | |
| CTCRGSGNLQEECEM | 316 | O60609 | |
| GPVCDCKRNSDVMDC | 836 | P54289 | |
| NCGREAMSECTGCHK | 506 | O75398 | |
| MLCTCLGNGVSCQET | 331 | P02751 | |
| QSITKMQCCCDAGRC | 351 | P35555 | |
| EGAACKCVEADCGQM | 1521 | P01031 | |
| CKRKLAMSRCETCGT | 211 | Q9NWK9 | |
| EVLMSSCSQCRACGA | 1486 | Q5VZ89 | |
| RDCSCGAKSCIMNSG | 361 | Q13443 | |
| ECMLFGSEICKEGKC | 996 | Q9NS15 | |
| MLCAGLESGGKDSCR | 616 | O00187 | |
| CDCNILGSRRDMPCD | 431 | Q13751 | |
| ECSLDMVCGALLRGC | 376 | Q5VZK9 | |
| DDCLMRPCANGATCL | 176 | Q6UY11 | |
| GGNCTEFQTELKCMC | 1271 | P82279 | |
| GKMNCDVCGLSCISF | 116 | Q9UKT9 | |
| QRETCIGMCKESCND | 436 | P51168 | |
| NGKLKCDVCGMVCIG | 156 | Q9H2S9 | |
| VCRCNVEGQCMRKVG | 761 | O75309 | |
| CGNDFQCSTGRCIKM | 101 | P02748 | |
| GGTVILMDGKCLCAC | 516 | P02748 | |
| MAGCCCLSAEEKESQ | 1 | O95837 | |
| AAMCGLCGLKAAVVC | 261 | O95045 | |
| CCLRAKIDMSSNNGC | 336 | P07814 | |
| GDCAEPSCLCEMKIR | 66 | Q8N8V8 | |
| GMLGSACVVCEDCKK | 106 | Q9Y2J0 | |
| TMKECNRCICQERGL | 896 | A2VEC9 | |
| SCGSLNMECRVCGDK | 66 | Q03181 | |
| MLSSAERGCPKGCRC | 26 | Q86VH5 | |
| DGTGCDNMTCIIICF | 491 | O15355 | |
| MGSKIFCCCRKTSEG | 1 | A0A1B0GU33 | |
| ENIMRKFSGSCRCCA | 76 | Q8WVD3 | |
| HGCMDRVLCLDCGEQ | 161 | Q9Y6E7 | |
| CMLVCGSRAGCSNIA | 336 | P53794 | |
| MGKCSGRCTLVAFCC | 1 | Q4KMZ8 | |
| GLIKSEGCNRMSCRC | 681 | Q9NWF9 | |
| SLGIMGTEKCCDNCR | 926 | Q14191 | |
| MVKCCSAIGCASRCL | 1 | Q8TBB0 | |
| CDEGKDCCDRMGSCK | 281 | Q4LDE5 | |
| KELNRTCCLNGGTCM | 76 | P13385 | |
| GVNDKVKCFCCGLML | 76 | Q13490 | |
| NSTGCLRMKDQCDKC | 291 | P10909 | |
| MGSCSGRCALVVLCA | 1 | Q8IVV8 | |
| MLCAGSLEGKTDACQ | 356 | Q9UL52 | |
| QMKCCRNGCGKVSCV | 106 | Q14508 | |
| IEKLDGCNKMTCTGC | 411 | Q9UBS8 | |
| LTSRGMDSCEVMCCG | 296 | P09544 | |
| MQCKTNGDCRVEECA | 26 | Q03405 | |
| MCRKKVGLTGFDCRC | 156 | O76080 | |
| SSLCKLCMGSGLNLC | 511 | P02787 | |
| IARQGMKCLECGVKC | 1121 | Q8NB66 | |
| DLECMSMGCVSGCLC | 796 | P04275 | |
| NKVNGVTCCTRMLGC | 941 | Q6ZVD8 | |
| MGSRKCGGCLSCLLI | 1 | Q96CE8 | |
| MCRKKVGLTGFECRC | 151 | Q6FIF0 | |
| KCMECGKAFCRVGDL | 246 | Q86UE3 | |
| DFCCEGCGSAMKDVL | 146 | Q9Y385 | |
| GRLCNKTSEGMDGCE | 301 | Q9H1J7 | |
| KTSEGMDGCELMCCG | 306 | Q9H1J7 | |
| TQACSMGELLQCGCQ | 121 | Q9Y6F9 | |
| CLDGMDRNGTCVCQE | 126 | Q9NY15 | |
| IARQGMRCSECGVKC | 501 | O14795 | |
| GRTCKERCSGQEGCK | 261 | Q02763 | |
| ESSVMGHLVCCLCGK | 1696 | Q9UGU0 | |
| CKSSVCGEIMGCSFL | 116 | Q9H7R0 | |
| CESLEGCHTLCLMGN | 301 | Q7Z3V4 | |
| EMKCKCHGVSGSCSI | 206 | O96014 | |
| QECKCHGMSGSCTVR | 216 | P04628 | |
| MKLECKCHGVSGSCT | 196 | O00755 | |
| CMRNLDECEVCRDGG | 686 | Q13342 | |
| QMCNKRSCPVDGCLS | 541 | P35442 | |
| RSCREGICGSCAMNI | 91 | P21912 | |
| KELNRTCCLNGGTCM | 76 | P51864 | |
| FLGCCGAIKESRCML | 71 | P19075 | |
| MAEACGGCDLQLNVC | 631 | A6NCI4 | |
| EICMREKPCQSNECG | 221 | Q0VGE8 | |
| GCLEERRDSQCKSMG | 501 | Q9BYP7 | |
| CNTDSLDMCISGICQ | 186 | P82987 | |
| LDMCISGICQAVGCD | 191 | P82987 |